Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma

Cytotoxic chemotherapy is commonly used to treat advanced Merkel cell carcinoma (MCC). However, its efficacy in distant metastatic MCC patients is unclear, in part because most prior reports aggregated these patients with those receiving adjuvant chemotherapy and combined chemoradiation for whom pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Jayasri G., Blom, Astrid, Doumani, Ryan, Lewis, Christopher, Tarabadkar, Erica S., Anderson, Austin, Ma, Christine, Bestick, Amy, Parvathaneni, Upendra, Bhatia, Shailender, Nghiem, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055152/
https://www.ncbi.nlm.nih.gov/pubmed/27431483
http://dx.doi.org/10.1002/cam4.815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055152/
https://www.ncbi.nlm.nih.gov/pubmed/27431483
http://dx.doi.org/10.1002/cam4.815

Ejemplares similares